Progress Toward UNAIDS Global HIV Pre-Exposure Prophylaxis Targets: CDC-Supported Oral Pre-Exposure Prophylaxis — 37 Countries, 2017─2023
MMWR. Morbidity and Mortality Weekly Report · 28.11.2024 · 73 (47) · 1082-1086
DOI: 10.15585/mmwr.mm7347a3 ↗Kurz gefasst
Fachartikel in der Zeitschrift MMWR. Morbidity and Mortality Weekly Report, online erschienen am 28.11.2024. Verfasst von Megan E Peck und 35 weiteren Autor:innen. Hauptthemen laut MEDLINE: Pre-Exposure Prophylaxis, HIV Infections, Centers for Disease Control and Prevention, U.S., Global Health. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Oral pre-exposure prophylaxis (PrEP) reduces HIV acquisition risk from sex by 99% and from injection drug use by ≥74% when used as recommended. The Joint United Nations Programme on HIV/AIDS (UNAIDS) has set a goal of 21.2 million persons using (initiating or continuing) PrEP globally in 2025. In 2016, CDC, with the U.S. President's Emergency Plan for AIDS Relief, joined ministries of health to implement PrEP globally. PrEP is beneficial for persons at substantial risk for acquiring HIV, including but not limited to key populations, which include female sex workers, men who have sex with men, persons in prisons and other enclosed settings, persons who inject drugs, and transgender persons. Annual country targets were used to guide scale-up. In 2023, CDC supported 856,816 PrEP initiations, which represents nearly one quarter of the 3.5 million persons globally who either initiated or continued PrEP that year. During 2017-2023, CDC supported PrEP initiations for 2,278,743 persons, 96.0% of whom were in sub-Saharan Africa. More than one half (64.0%) were female and 44.9% were aged 15-24 years. Overall, CDC achieved 118.7% of its PrEP initiation targets for the 7-year period. Among PrEP initiations for key populations, the majority in sub-Saharan Africa were female sex workers, whereas in Southeast Asia, Eurasia, and the Americas, the majority were men who have sex with men. Continued rapid scale-up is needed to meet the UNAIDS goal to end HIV as a public health threat.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Peck, M. E., Davis, S., Odoyo-June, E., Mwangi, J., Oyugi, E., Hoang, T., Canda, M., Seleme, J., Bock, M., Ndeikemona, L., Dladla, S., Machava, R., Nyagonde, N., Mashauri, A., Awor, A. C., Alamo, S., Chituwo, O., Chisenga, T., Malaba, R., …, & Bhatia, R. (2024). Progress Toward UNAIDS Global HIV Pre-Exposure Prophylaxis Targets: CDC-Supported Oral Pre-Exposure Prophylaxis — 37 Countries, 2017─2023. MMWR. Morbidity and Mortality Weekly Report, 73(47), 1082-1086. https://doi.org/10.15585/mmwr.mm7347a3
Vancouver
Peck ME, Davis S, Odoyo-June E, Mwangi J, Oyugi E, Hoang T, et al. Progress Toward UNAIDS Global HIV Pre-Exposure Prophylaxis Targets: CDC-Supported Oral Pre-Exposure Prophylaxis — 37 Countries, 2017─2023. MMWR. Morbidity and Mortality Weekly Report. 2024;73(47):1082-1086. doi:10.15585/mmwr.mm7347a3
BibTeX
@article{Peck2024,
author = {Peck, Megan E and Davis, Stephanie and Odoyo-June, Elijah and Mwangi, Jonathan and Oyugi, Elvis and Hoang, Thai and Canda, Marcos and Seleme, Jessica and Bock, Maria and Ndeikemona, Lylie and Dladla, Sibongile and Machava, Richard and Nyagonde, Nyagonde and Mashauri, Abdul and Awor, Anna Colletar and Alamo, Stella and Chituwo, Omega and Chisenga, Tina and Malaba, Rickie and Mutseta, Miriam and Angumua, Carrine and Nkwoh, Kingsly Tse and Ricketts, Janique and Gordon-Johnson, Kelly-Ann and Adamu, Victor and Adamu-Oyegun, Scott and Benson, John Mondi and Bunga, Sudhir and Farach, Nasim and Castaneda, Carlos and Bonilla, Luis and Premjee, Sharmeen and Demeke, Hanna B and Djomand, Gaston and Toledo, Carlos and Bhatia, Ramona},
title = {Progress Toward UNAIDS Global HIV Pre-Exposure Prophylaxis Targets: CDC-Supported Oral Pre-Exposure Prophylaxis — 37 Countries, 2017─2023},
journal = {MMWR. Morbidity and Mortality Weekly Report},
year = {2024},
volume = {73},
number = {47},
pages = {1082--1086},
doi = {10.15585/mmwr.mm7347a3}
}
EUVIMED